Vanguard Group »

Fennec Pharmaceuticals shares owned by Vanguard Group

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 1.1M 11.22
2023-09-30 $614k 82k 7.51
2023-06-30 $705k 80k 8.83
2021-03-31 $693k 111k 6.22
2020-12-31 $727k 98k 7.45
2020-09-30 $516k 85k 6.06
2020-06-30 $754k 90k 8.35
2019-03-31 $219k 45k 4.85
2018-12-31 $266k 42k 6.39
2018-09-30 $357k 44k 8.21
2018-06-30 $424k 41k 10.43